英特格
ENTG
138.74
-8.13
-5.54%
英特格
US · ENTG
#831 按市值排名
上市于 1970
138.74
-8.13
-5.54%
实时 - 追踪5344个代码 - 心跳于1秒前
· 2026-10-16 20:02
✦ 量化股权信号 计算方式说明
减持
- 最近一期(2026/Q3)披露持股的机构数量减少了2家。
- 机构持股总比例下降了0.4个百分点。
机构持股
- 机构持股比例
- 109.27% -0.36pp
- 机构数量
- 857 -2
- 数据截至
- 2026/Q3 较上一报告期
持股变动 vs 资金流向
方向一致机构在上一报告期减持了股份,同时该股在最近20个交易日的主力资金呈净流出——两者方向一致。
机构持股变动数据按季度发布且存在滞后;资金流向数据为每日更新。请将其作为方向性的交叉验证参考,而非精确的择时信号。
持股人类型
Mutual Fund92.92%
Public Company6.18%
Hedge Fund3.83%
Government Pension Fund1.85%
Private Company1.76%
Sovereign Wealth Fund1.50%
Family Office/Trust0.45%
VC/PE Fund0.44%
Individual/Insider0.37%
主要股东 截至 2026-06-30
BlackRock
13.40% · 20.48M 股
T. Rowe Price Group, Inc.
8.39% · 12.82M 股
Capital Research
7.34% · 11.21M 股
Vanguard Capital Management, LLC
5.14% · 7.86M 股
Vanguard Portfolio Management, LLC
5.09% · 7.78M 股
Principal Global Investors, LLC
3.90% · 5.96M 股
State Street Global Advisors
3.61% · 5.52M 股
Invesco Ltd.
3.14% · 4.80M 股
J.P. Morgan Asset Management, Inc.
2.38% · 3.63M 股
PRIMECAP Management Company
2.05% · 3.13M 股
条形长度是相对于此处列出的最大股东而言,并非相对于公司100%股权。
内部人持股
共追踪50份申报 · 17次买入 · 33次卖出
| 姓名 | 职务 | 持股比例 |
|---|---|---|
| Bertrand Loy | Chief Executive Officer | 0.15% |
| Susan Rice | Senior Vice President of Global Human Resources | 0.04% |
| Clinton Haris | Senior VP & President of Microcontamination Control | 0.04% |
| Daniel Woodland | Senior VP & President of Advanced Planarization Solutions | 0.02% |
| Azita Saleki | Independent Director | 0.02% |
| Joseph Colella | Senior VP, General Counsel, Chief Compliance Officer & Secretary | 0.01% |
| Neil Richards | Senior Vice President of Global Operations, Supply Chain & Quality | 0.01% |
| James Gentilcore | Lead Independent Director | 0.01% |
| James Lederer | Independent Director | 0.01% |
| Linda LaGorga | Senior Vice President | 0.01% |
内部人交易 最近的 Form 4 申报记录
| 日期 | 姓名 | 职务 | 类型 | 股数 | 价格 |
|---|---|---|---|---|---|
| 2026-08-17 | David Reeder | Director | Sale to Issuer | -5,386 | $150.27 |
| 2026-08-13 | Olivier Blachier | Senior Vice President of Business & New Markets Development | Derivative Exercise and Sale | -2,000 | $80.71–160.66 |
| 2026-08-12 | Joseph Colella | Senior VP, General Counsel, Chief Compliance Officer & Secretary | Derivative Exercise and Sale | -3,916 | $98.11–164.48 |
| 2026-08-10 | Susan Rice | Senior Vice President of Global Human Resources | Open Market Disposition | -2,062 | $149.52 |
| 2026-08-02 | Robert Bruggeworth | Director | Other Acquisition | +1,329 | -- |
| 2026-06-10 | Linda LaGorga | Senior Vice President | Intent to Sell (Form 144) | -2,859 | $145.00 |
| 2026-06-02 | James Lederer | Independent Director | Open Market Disposition | -3,569 | $143.59 |
| 2026-05-26 | Clinton Haris | Senior VP & President of Microcontamination Control | Derivative Exercise and Sale | -6,848 | $98.11–149.23 |
| 2026-05-25 | Linda LaGorga | Senior Vice President | Intent to Sell (Form 144) | -2,860 | $140.00 |
| 2026-05-21 | Linda LaGorga | Senior Vice President | Intent to Sell (Form 144) | -2,389 | $135.00 |
| 2026-05-17 | Sukhi Nagesh | Chief Financial Officer | Other Acquisition | +8,254 | -- |
| 2026-05-14 | Susan Rice | Senior Vice President of Global Human Resources | Open Market Disposition | -6,933 | $133.01 |
| 2026-05-14 | Susan Rice | Senior Vice President of Global Human Resources | Derivative Exercise and Sale | -12,960 | $55.72–132.75 |
| 2026-05-13 | Clinton Haris | Senior VP & President of Microcontamination Control | Derivative Exercise and Sale | -5,830 | $55.72–144.57 |
| 2026-05-13 | Joseph Colella | Senior VP, General Counsel, Chief Compliance Officer & Secretary | Derivative Exercise and Sale | -6,326 | $80.71–140.25 |
| 2026-05-13 | Olivier Blachier | Senior Vice President of Business & New Markets Development | Derivative Exercise and Sale | -2,000 | $80.71–140.04 |
| 2026-05-05 | James Gentilcore | Lead Independent Director | Other Acquisition | +1,412 | -- |
| 2026-05-05 | Mary Puma | Independent Director | Other Acquisition | +1,412 | -- |
| 2026-05-05 | James Lederer | Independent Director | Other Acquisition | +1,412 | -- |
| 2026-05-05 | Yvette Gordon-Kanouff | Independent Director | Other Acquisition | +1,412 | -- |
Form 4 申报记录,每家公司显示最新的一批。"Other Derivative Acquisition"(其他衍生品获取)类目多为限制性股票/期权归属,并非公开市场买入——具体类型见"类型"列。
报价时间 2026-10-16 20:02:22 · 仅供参考,不构成投资建议,也未考虑您的具体情况。
英特格 讨论区 0 条评论